Company intelligence / Profile preview

Amersham plc

Amersham/Little Chalfont, Buckinghamshire, United Kingdomcytivalifesciences.com ↗

Ownership: Private
Employees: ~8900
Development stage: Other

Overview

Amersham was a leading producer of contrast agents used in medical diagnostics, with products like Omnipaque and Visipaque being industry standards. The company also produced radiotherapies for cancer treatment.

Therapeutic areas: OncologyOther
Modalities: Radiopharmaceuticalscontrast agentsdiagnostic imaging agents
Industry: Biotech

Partnerships

Joint venture with Pharmacia and Upjohn to form Amersham Pharmacia Biotech (1997)Merger with Nycomed (1997)

Beyond the preview

Go deeper on Amersham plc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amersham plc.